Veracyte
$57.08
90
-$2.77-4.63% Thursday 20:00
-$0.62-1.09%Thursday 23:58After hours
Statistics
Day High
57.1
Day Low
56.99
52W High
60.91
52W Low
22.61
Volume
44,245
Avg. Volume
-
Mkt Cap
4.55B
P/E Ratio
56.01
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11AugExpected
Expected EPS
0.42833
Actual EPS
N/A
Financials
12.83%Profit Margin
Profitable1.03BRevenue
132.71MNet Income
Analyst Ratings
49.67Average Price Target
The highest estimate is 65.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 17%
Sell 17%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow VCYT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap19.79B
Illumina
ILMN
Mkt Cap28.55B
Fulgent Genetics
FLGT
Mkt Cap566.88M
Bionano Genomics
BNGO
Mkt Cap13.2M
Pacific Biosciences of California
PACB
Mkt Cap521.81M
Qiagen NV
QGEN
Mkt Cap8.13B
Myriad Genetics
MYGN
Mkt Cap555.36M
Intellia Therapeutics
NTLA
Mkt Cap2.45B
About
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Show more...
CEO
Mr. Marc A. Stapley
Employees
755
Country
United States
ISIN
US92337F1075
Listings
0 Comments
Share your thoughts
FAQ
What is Veracyte stock price today?▼
The current price of VCYT is $57.08 USD — it has decreased by -4.63% in the past 24 hours. Watch Veracyte stock price performance more closely on the chart.
What is Veracyte stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Veracyte stocks are traded under the ticker VCYT.
Is Veracyte stock price growing?▼
VCYT stock has fallen by -5.17% compared to the previous week, the month change is a +17.14% rise, over the last year Veracyte has showed a +104.22% increase.
What is Veracyte market cap?▼
Today Veracyte has the market capitalization of 4.55B
When is the next Veracyte earnings date?▼
Veracyte is going to release the next earnings report on August 11, 2026.
What were Veracyte earnings last quarter?▼
VCYT earnings for the last quarter are 0.52 USD per share, whereas the estimation was 0.33 USD resulting in a +55.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Veracyte revenue for the last year?▼
Veracyte revenue for the last year amounts to 1.03B USD.
What is Veracyte net income for the last year?▼
VCYT net income for the last year is 132.71M USD.
How many employees does Veracyte have?▼
As of July 06, 2026, the company has 755 employees.
In which sector is Veracyte located?▼
Veracyte operates in the Health & Wellness sector.
When did Veracyte complete a stock split?▼
Veracyte has not had any recent stock splits.
Where is Veracyte headquartered?▼
Veracyte is headquartered in South San Francisco, United States.